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The genome of most plant viruses is composed of RNA of ‘+’ polarity and can serve directly as messenger 
for protein synthesis. This paper deals with those viral RNAs whose in vitro and in vivo translation products 
can be compared; it reviews the strategies used for the modulation of the synthesis of the various virus-coded 
proteins and examines the postulated functions of these proteins. 
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1. INTRODUCTION 
The genome of plant viruses is composed of one 
or several single-stranded (ss) or double-stranded 
(ds) RNA or DNA molecules. Among DNA viruses 
the caulimoviruses, of which cauliflower mosaic 
virus is the main representative, possess a ds DNA 
genome with ss interruptions, and geminiviruses 
with mono- or bipartite morphology possess a cir- 
cular ss DNA genome. The vast majority of plant 
viruses possess a ss RNA genome of + polarity 
since their RNAs are used directly as messenger 
RNA. There exist only few plant viruses whose 
genome is composed of ds RNA (plant reoviruses, 
e.g., wound tumor virus) or of ss RNA of - polarity 
(complementary to mRNA; plant rhabdoviruses, 
e.g. tomato spotted wilt virus); in these cases, the 
RNA is first transcribed and only then translated. 
toms induced by the associated virus and is often 
not translated: the helper virus is not dependent on 
the satellite) and virusoids (containing viroid-like 
RNA in addition to virus-like, linear RNA; the 
viroid-like RNA possesses properties in common 
with viroids and satellite RNAs, and in some cases 
it seems to be required for virus infectivity). 
Among plant pathogens [l] there exist also 
viroids (free-living small circular ss RNAs that in- 
duce their own replication and are not translated), 
satellite particles (whose small linear RNA requires 
a helper virus for replication, modifies the symp- 
Plant viruses with a ss RNA genome of + polarity 
are not only the majority but are also the best 
studied from all points of view: structure, replica- 
tion, translation, encapsidation and function of 
the virus-coded proteins. The viral RNA must pos- 
sess information for its replication, translation, en- 
capsidation and propagation. The viral genome is 
composed of one, two or three distinct RNA 
molecules. The RNAs of bi- and tripartite genome 
viruses are numbered 1 to 3 in order of their 
decreasing molecular mass. There also exist sub- 
genomic RNAs which are usually 3’ co-terminal 
with one of the genomic RNAs and are packaged 
when they possess the encapsidation site. The viral 
RNAs are encapsidated in the same and/or distinct 
virus particles, the capsid being generally made up 
of a single protein species. 
* Present address: Allelix Inc., 6850 Goreway Drive, The multiplication cycle of RNA viruses with a 
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mitted mechanically, by the seeds, insects, etc., 
enters the cell probably by endocytosis and is rapid- 
ly uncoated. The viral RNA(s) is (are) translated 
giving rise to high molecular mass proteins; these 
are involved either directly or indirectly in virus 
RNA replication. Other proteins involved in virus 
replication are synthesized by the host during the 
first few hours following infection. An RNA- 
dependent RNA polymerase generates negative 
sense RNA strands from the genomic RNAs of + 
polarity. The progeny virus RNA strands are then 
s~thesized on replicative intermediates yielding 
genomic and subgenomic RNAs that are trans- 
lated. Concomitantly to coat protein synthesis, the 
viral RNAs are encapsidated. Short and long 
distance virus migration then follows and infection 
is established. 
Recent review articles have described the struc- 
ture [3-51, replication [6] and translation [4,5] of 
plant viral RNAs. This article briefly summarizes 
our present knowledge of the structures at the 5’ 
and 3’-ends of viral RNAs, and then deals with 
plant viral RNAs whose in vitro and in vivo 
translation can be compared, the strategies used 
for the synthesis of more than one polypeptide per 
cistron, the regulation of the synthesis of the dif- 
ferent virus-coded proteins and the postulated 
functions of these proteins. 
A list of plant RNA viruses (main representa- 
tives only), the group to which they belong, the 
type and structure of their genome and the major 
strategies used during translation of their RNAs 
are presented in table 1. 
2. STRUCTURE OF VIRAL RNAs 
The complete nucleotide sequence of the TMV 
181, AMV [g-11], CPMV 112,131 and BMV geno- 
mic RNAs [14,15], the TSV genomic RNA 3 [16], 
the CMV genomic RNA 3 [17] and the TYMV sub- 
Table 1 
Terminal structure and major translation strategies used by the RNA genomes of + polarity of plant viruses (references 
cited in [3-71) 
Genome Virus Virus Structure+ Translational 
group 5’ 3’ strategiesb 
Monopartite Tobamo tobacco mosaic virus (TMV) cap tRNAHiS sg; RT 
Tobamo sun hemp mosaic virus @HMV) cap tRNAVa’ sg; RT 
Tymo turnip yellow mosaic virus (TYMV) cap tRNAVa’ sg; pre term; RT; cleav 
Potex potato virus X (PVX) cap pXOH sg?; RT 
Poty tomato etch virus (TEV) VPg poly(A) sg?; RT?; cleav? 
unclass. carnation mottle virus (CarMV) ? pXOH polycistronic 
Bipartite Tobra tobacco rattle virus (TRV) cap pXOH sg; RT 
Corn0 cowpea mosaic virus (CPMV) VPg poly(A) cleav; int init 
Nepo tobacco black ring virus (TBRV) VPg poly(A) cleav 
Bi- and tripartite Hordei barley stripe mosaic virus (BSMV) cap tRNATY’ sg 
Tripartite Bromo brome mosaic virus (BMV) cap tRNATy’ sg 
Bromo cowpea chlorotic mottle virus (CCMV) cap tRNATy’ sg 
Cucumo cucumber mosaic virus (CMV) cap tRNATy’ sg 
Bar alfalfa mosaic virus (AMV) cap pXOH sg; pre term; frame? 
Bar tobacco streak virus (TSV) cap pXOH sg 
aThe viral RNAs possess at their S-terminus a cap (m7Gs~ppps, X -) or a VPg (virus-coded protein) linked covalently 
to the genome and at their 3’4erminus a poly(A) stretch, a tRNA-like region or a heteropolymeric sequence with no 
particular structure (-pXOH) 
b These include the use of(i) internal initiation (int init), premature termination (pre term), readthrough (RT) and frame- 
shift (frame) during translation, (ii) post-translational cleavage (cleav) of a polyprotein, (iii) polycistronic RNA and 
(iv) subgenomic (sg) RNA. ? = undefined 
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genomic coat protein mRNA [ 181 has been estab- 
lished. However, only partial information can be 
drawn from these sequences about the presence 
and location of the various signals involved in 
virus multiplication. For several other plant viral 
RNAs, only the nucleotide sequence in the region 
of the 5’- and 3’-ends is known (reviews, [3-51). 
In nearly all instances the viral RNAs carry at 
their 5’-terminus either a cap (m7Gs~ppps~Xp-) or a 
virus-coded genome-linked protein (VPg); at their 
3’-end they possess either a tRNA-like structure, a 
poly(A) stretch or a heteropolymeric sequence 
without particular features (see table 1). 
The cap structure facilitates translation of plant 
viral RNAs [19,20] as it does for most eukaryotic 
mRNAs. The presence of the VPg does not in- 
fluence translation of plant viral RNAs in wheat 
germ extracts or reticulocyte lysates, and it is still 
unclear whether it is necessary for infection; by 
analogy with the poliovirus, one could expect the 
VPg to be involved in replication (review, (211). 
The tRNA-like structure formed by the 3’-region 
of several plant viral RNAs is recognized in vitro 
and in vivo by many tRNA-specific enzymes 
(reviews, 122,231). The folding of the tRNA-like 
region of the bromo-, cucumo- and hordeiviruses 
is highly conserved [24-261. It has been shown that 
the purified ‘replicase’ is able to replicate viral 
RNAs without prior aminoacylation ([27-291; 
review, [6]). It follows that the aminoacylation of 
viral RNAs can not be required for viral RNA 
replication. It has been suggested that aminoacyla- 
tion might not be required at early stages of BMV 
multiplication 1301. The 3’-regions of these viral 
RNAs must play an important role in viral RNA 
replication, but the exact function of viral RNA 
aminoacylation is not understood. 
The length of the poly(A) stretch located at the 
3’-end of a number of plant viral RNAs is hetero- 
genous for the RNAs of a given virus. The role of 
the poly(A) stretch is unclear although it has been 
reported that poly(A) stabilizes the RNAs [31]. 
Whether the poly(A) stretch is synthesized uring 
or after replication remains to be elucidated be- 
cause the S-terminal sequence of the - strand of 
these viruses as well as the replication signal for 
initiation are unknown. Certain plant viral RNAs 
contain an internal poly(A) sequence of 19-40 resi- 
dues; in BMV RNA 3 the poly(A) stretch is present 
in the intercistronic region [14], and in BSMV 
RNA between the 3’“terminal cistron and the 
tRNA-like region [32]. It has been suggested [32] 
that the formation of the poly(A) sequence could 
occur by ‘slippage’ during pol~erization or by re- 
iterative copying of the corresponding poly(U) in 
the - RNA strand. 
Finally, some plant viral RNAs contain a hetero- 
polymeric region without particular sequence or 
structure at the 3’-end. This is the case of the AMV 
and TSV RNAs; interestingly, coat protein inter- 
action with the 3’-region is required for replication 
of these viral RNAs [33]. 
3. IN VITRO AND IN VIVO TRANSLATION 
OF PLANT VIRAL RNAs 
Several systems have been used to examine the in 
vitro (wheat germ, reticulocyte and ascites ex- 
tracts) and in vivo (leaf fragments, protoplasts and 
Xenopus faevis oocytes) translation of plant viral 
RNAs. The genetic map of a few plant viral RNAs 
is well established. Those whose in vitro and in 
vivo translation products are well characterized 
and can be compared are presented in fig. 1 and are 
discussed below. 
In general, for a given virus at least 3 proteins 
are synthesized. The RNAs of viruses with a mono- 
partite genome are usually polygenic, and those of 
viruses with a bi- or tripartite genome are mono- 
and/or polygenic. In nearly all cases, the viral 
RNAs are functionally monocistronic: only the 
5’-proximal cistron is transIated. Subgenomic 
RNAs, on which the internal genes carried by the 
genomic RNA become 5’-proximal are generally 
responsible for the translation of these genes. 
In the case of TMV, the monopartite genomic 
RNA codes in phase for two high-molecular-mass 
proteins, and the two subgenomic RNAs code for 
a 30-kDa protein and for the coat protein, respec- 
tively (fig.1; [20,34-411). Interestingly, a similar 
pattern of protein synthesis is found with TRV 
whose genome is segmented: the molecular masses 
of the proteins encoded by its RNAs are about the 
same 1421 as those of TMV RNA. The two high- 
molecular-mass proteins are synthesized on genom- 
ic RNA 1, whilst the coat protein is exceptionally 
encoded by the S-proximal cistron of genomic 
RNA2 and the 30-kDa protein by a subgenomic 
RNA deriving from the 3’-region of RNA 2 [43]. 
Como- and nepoviruses possess a bipartite 
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Fig.1. Gene.., ,,qr of plant virus RNAs of + polarity 
based on in vitro and in vivo experiments. The following 
genetic maps are shown: TMV RNA [8,20,34-411, TRV 
RNA campinas strain [42,43], CPMV RNA ([13,44-461 
review, [21]), BMV RNA [47-491 and AMV RNA 
[SO-551. The genetic map of CCMV RNA 156,571 isvery 
similar to that of BMV RNA. The genetic map of BSMV 
RNA has recently been reported f58.591 but is not pre- 
sented here since it is based essentially on in vitro data, 
and since a relationship between ail the in vitro and 
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virus-coded or virus-induced in vivo transiation products 
has not yet been established. (*) cap sructure; (An) 
poIy(A) stretch; (+) tRHA-like structure; (m) VPg; 
(0) RNA; (II) protein; (A, A) open and dosed 
initiation sites for translation, respectively; (0) termina- 
tion codon; (0) premature termination due to a ‘stop’ 
codon different from termination codons; (r) frame- 
shift; (_f) post-translational cleavage; (sg) subgenomic; 
(cp) coat protein; {K) kilodalton; (r) proteins detected 
only upon in vitro tr~s~at~on of the packaged RNAs; 
(*) proteins detected onfy in vitro; (?) protein detected 
neither in vivo nor in vitro. All other proteins have been 
detected both in vivo and in vitro. 
goname; their RNAs direct the synthesis of 3 high- 
molecular-mass proteins. One of them is encoded 
by RNA 1 (also referred to as B RNA) and gives 
rise after post-translational cleavage to the repli- 
case or to a subunit thereof, and to VPg [44]. The 
two otbers are synthesized by in-phase reading on 
RNA 2 (also referred to as M RNA) and both are 
post-translationally cleaved to generate the coat 
proteins ([45,46]; review, [21]). 
In bromo-, cucumo- and ilarviruses with a tri- 
partite genome, RNAs 1 and 2 direct the synthesis 
of two high-molecular-m~s proteins, and RNA 3 
of a 3%kDa protein. In addition, a subgenomic 
RNA 4 pertaining to the 3’-region of RNA 3 directs 
the synthesis of the coat protein [47-571. Based on 
RNA sequence data, it has been demonstrated that 
two regions of the protein encoded by BMV RNA 1 
and AMV RNA 1 are strikingly similar; moreover, 
the central portions of the proteins encoded by 
BMV RNA 2 and AMV RNA 2 also contain con- 
siderable sequence homology, suggesting common 
functions for these two pairs of high-molecular- 
mass proteins ]60,61]. 
4. STRATEGIES USED FOR THE EXPRESSION 
AND REGULATION OF VIRUS-CODED 
PROTEINS 
Plant RNA viruses resort to several strategies to 
synthesize more than one polypeptide per cistron, 
and to regulate the synthesis of their genomic 
and/or subgenomic RNA-coded proteins. These 
strategies include: the existence of multipartite 
RNA genomes, the formation of (a) subgenomic 
RNA(s), readthrough, post-tra~latioual cleavage, 
the presence of multi-initiation sites on monocis- 
tronic mRNAs, premature termination, frameshift 
(see table 1) and differential translation efficiency. 
Only those strategies utilized during translation 
will be considered here. 
As is the case in eukaryotic systems, in plant 
viral RNAs also, the first AUG triplet from the 
5’-end generally serves for initiation of translation, 
However, in CPMV RNA2, the first AUG triplet 
is silent, but both the second and the third AUGs 
from the Y-terminus are efficiently used in phase 
for in vitro translation [12,21,45]. In at least one 
strain of AMV, the first AUG on RNA 1 is fol- 
lowed in phase by a UGA codon [93. 
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An interesting and exceptional situation is that 
of CarMV whose RNA might resemble a pro- 
karyotic RNA insofar as all 3 cistrons of its geno- 
mic RNA seem to be translated in vitro probably 
by internal initiation [62]. This translation strategy 
needs to be confirmed. 
4.2. Eiongation of trandation 
Two types of regulation can occur during the 
elongation of peptide chains: premature termina- 
tion or a shift in the reading frame. These modali- 
ties appear to take place during translation of 
AMV RNAs 1 and 3, respectively. 
During translation of AMV RNA 1 in a reticulo- 
cyte lysate, in addition to the full-length transla- 
tion product, two shorter proteins are synthesized 
by premature termination. The synthesis of the 
two low-molecule-mass proteins appears to be 
due to the lack of a glutamine-charged tRNA, 
since upon addition of either glutamine or of the 
corresponding tRNA an increase in the synthesis of 
the full-length translation product ensues [52]. 
Surprisingly, no particular feature in the sequence 
or structure of RNA 1 can be discerned in the 
region corresponding to the C-terminal portion of 
the low-molecular-mass proteins, except that a 
coat protein binding site is present about halfway 
down the RNA molecule [63]. 
In a wheat germ extract [50] and in vivo in 
AMV-infected tobacco leaves [55], AMV RNA 3 
directs the synthesis of a 3%kDa polypeptide and 
of a higher-molecular-mass protein. Based on the 
sequence of AMV RNA 3, the synthesis of the 
high-molecular-mass protein can be explained by 
two +l frameshifts or by readthrough of the UCA 
termination codon at the end of the 35kDa protein 
gene followed by one -1 frameshift [55]. The 
higher-molecular-mass protein is recognized by the 
antibodies raised against the 35-kDa protein and 
against the virus. However, direct confirmation of 
the use of frameshift during translation will have 
to await sequencing of the high-molecular-mass 
protein. 
4.3. Termination of translation 
The 5’-proximal cistron of the genomic RNA of 
TMV [36] and of TYMV [64] is terminated by a 
UAG codon and that of TRV RNA 1 by a UGA 
codon (H. Beier, personal communication). The 
readthrough of these codons occurs to a certain ex- 
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tent in the presence of total (host) tRNAs and is in- 
creased by addition in vitro of the corresponding 
(host-coded) suppressor tRNAs. Readthrough of 
the TMV and TYMV UAG codons is also favored 
in vitro by the presence of polyamines uch as sper- 
mine or spermidine; it has been suggested that this 
could occur via conformational changes in a tRNA 
[64]. A tRNATy’ isolated from Drosophila melano- 
gaster [65], from tobacco leaves [66] and from 
wheat germ or wheat leaves [67] devoid of modifi- 
cation in the first position of the anticodon has 
recently also been shown to suppress the UAG 
codon during translation of TMV RNA. In an in 
vitro system, readthrough of the UAG termination 
codon increases at low rather than at high TMV 
RNA concentration (201, suggesting that in vivo 
synthesis of the readthrough product could be 
favored early upon infection; this conclusion is 
strengthened by results obtained in vivo 1681. 
4.4. Post-translational cleavage 
Upon in vitro and in vivo translation of the 
comovirus RNAs, high-molecular-mass proteins 
are synthesized which undergo post-translational 
cleavages to produce mature proteins. Two pro- 
teins deriving from the CPMV RNA l-encoded 
200-kDa polyprotein contain protease activity. The 
32-kDa protein is involved in the cleavage of the 
primary translation products of RNA 2 1461. The 
second protease (24 kDa) probably participates in 
the processing of the 200-kDa polyprotein itself 
[69]; this observation is strengthened by computer 
data [70]. Indeed, there exists considerable amino 
acid sequence homology between the C-terminal 
portion of the 24-kDa protein and the C-terminal 
region of P3-7c, the protease of poliovirus. 
A similar situation probably exists among the 
nepoviruses [71] and the potyviruses [72-741. 
Upon in vitro translation of their RNA, a polypro- 
tein is synthesized from which functional proteins 
are derived by proteolytic cleavage. It is remark- 
able that picornaviruses (review, [75]) as well as 
coma-, nepo- and potyviruses which all bear a VPg 
and a poly(A) stretch at their 5’- and 3’-terminus 
respectively, should have adpoted the same trans- 
lational strategy. 
in the case of TYMV RNA only two of the 3 
high-molecular-mass proteins are cleaved in vitro 
[76]; the protease activity could be located in the 
C-terminal part of these proteins [77]. 
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4.5. Efficiency of translation 
In general, the coat protein mRNA is much 
more efficient in translation than are the genomic 
RNAs. This has been established by examining the 
in vitro translation of total (genomic and sub- 
genomic) RNAs: at high RNA concentrations, 
translation of the coat protein mRNA is favored 
whereas that of the genomic RNA is reduced 
[51,78-SO]. Coat protein is synthesized in vivo in 
much larger amounts than the genomic RNA- 
coded proteins and even in larger amounts than 
would be expected of the 5 : 1 ratio of subgenomic 
to genomic RNA usually encapsidated; consequent- 
ly, the subgenomic oat protein mRNA is very effi- 
ciently translated. These RNAs all possess a 5’-ter- 
minal cap structure. They differ in their leader 
sequences, and apart from the fact that the length 
of this region in the coat protein mRNA is general- 
ly short, it is still unknown why certain mRNAs are 
more efficient templates than others (review, [5]). 
There also exist certain subgenomic RNAs that 
are less efficient in translation than genomic or 
other subgenomic RNAs. As recently shown in 
TMV RNA, the subgenomic intermediate-length 
RNA 2 (12 RNA) is uncapped and is less efficient in 
translation than the capped genomic RNA [20]. 
5. POSSIBLE FUNCTIONS OF VIRUS-CODED 
PROTEINS 
Several proteins encoded by the viral genome 
participate, at least in part, in RNA replication and 
encapsidation. The virus-coded proteins may be 
multifunctional and/or act in association with host 
proteins (reviews, [5-71). 
5.1. Coat protein 
The most obvious function of the coat protein is 
to encapsidate the viral RNA and to protect it from 
nucleases. The coat protein-viral RNA interaction 
must be stable and highly specific to avoid inadver- 
tent packaging of cellular RNAs. 
Recently, it has been demonstrated that in TMV, 
a 26.5-kDa protein, previously referred to as the 
host-coded ‘H’ protein, shares sequences with the 
coat protein (17.5 kDa), and is also present in the 
virions to the extent of one molecule per virus par- 
ticle [81,82]. The function of this protein remains 
unknown. 
In ilarviruses, the coat protein also has a func- 
tion in ‘genome activation’: two to six molecules of 
coat protein per viral RNA are required for infec- 
tion ([33]; review, [7]). The coat proteins of dif- 
ferent ilarviruses such as AMV and TSV are inter- 
changeable although they possess no sequence 
similarity. Even though the sequences at the 3’-end 
of the TSV and AMV RNAs are different, they 
possess imilar secondary structures. There exists a 
high-affinity site for the coat protein in the 3’-region 
of the genomic RNAs. It has been proposed that 
coat protein-RNA interaction could be involved in 
template recognition by the ‘replicase’. Removal 
of the N-terminal region of the protein molecule 
(831 renders the coat protein inactive in this 
respect. 
5.2. ‘Replicase’ 
At least two virus-coded proteins could be in- 
volved in TMV RNA replication [84,85], and one 
in TYMV RNA replication [29]. A more direct 
indication that virus-coded proteins must either 
directly or indirectly be involved in replication of 
the viral RNA comes from viruses with a bi- or tri- 
partite genome in which the larger or the two 
largest genomic RNAs respectively, can replicate 
independently [21,49]. 
In CPMV, the RNA l-encoded 60-kDa protein 
present in the membranous fractions is the direct 
precursor of the VPg of about 4 kDa. VPg could 
be involved in initiation of replication by acting as 
primer for the initiation of RNA synthesis, or it 
could discriminate between those RNA molecules 
to be encapsidated and those to serve as mRNA for 
viral protein synthesis [21]. The 1 IO-kDa protein 
resulting from post-translational cleavage of the 
200-kDa protein constitutes the core of the RNA 
replication complex [86]. In support of a role of 
the 1 IO-kDa protein in RNA replication is the ob- 
servation that there exists significant sequence 
homology between the 87-kDa domain of the 
llO-kDa protein of CPMV and the polymerase 
from two picornaviruses, foot-and-mouth disease 
virus and poliovirus [70]. 
In bromo- and cucumoviruses uch as BMV [28] 
and CMV [27], the replicase has been purified ex- 
tensively. Interestingly, there exists a 1 IO-kDa pro- 
tein in the replicating system of the BMV RNA 
whose peptide map is virtually identical to that of 
the llO-kDa protein encoded in vitro by BMV 
RNA 1 [28]. This demonstrates clearly that at least 
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one virus-coded protein is involved in viral RNA 
In AMV the translation product(s) of RNA 3 are 
replication. It has been demonstrated that the 
N-terminal and the C-terminal regions of the 
involved in the regulation of the synthesis of the + 
1 lo-kDa protein encoded by BMV RNA 1 bear 
considerable sequence homology with the corres- 
and - strand RNA populations [87]. 
ponding regions in the 115kDa protein of AMV 
RNA 1 and the 126-kDa protein of TMV RNA, 
supporting the notion that all 3 proteins may 
operate equivalent functions in these viruses 
[60,61]. BMV RNA 2 and AMV RNA 2 are also re- 
quired for viral replication; in support of this is the 
observation that the central portion of their pro- 
teins is strikingly similar. Since it is also homo- 
logous to the C-terminal portion of the TMV read- 
through protein of 183-kDa, these 3 proteins may 
play a similar role [60,61]. 
Nothing is known concerning the nature of the 
host proteins involved in replication of the viral 
RNAs nor what determines host specificity. 
Generally, in infected protoplasts, the host-coded 
proteins are synthesized uring the first 8 h of in- 
fection [88]. Inhibition of transcription during this 
period results in inhibition of viral RNA replica- 
tion although the viral RNAs which served for 
infection are translated [89]. 
5.3. The 30-35-kDa protein 
A 30-35-kDa protein is synthesized in tobamo-, 
tobra-, bromo-, cucumo- and ilarviruses; its func- 
tion is still a matter of speculation. It has been sug- 
gested that the TMV RNA-coded 30-kDa protein 
could be involved in cell-to-cell movement of the 
virus [90]. Nucleotide sequence analysis of the 
30-kDa protein gene has revealed that the wild type 
and the cell-to-cell movement-deficient s rain (Lsl) 
of TMV differ by only one amino acid in the 
30-kDa protein [91]. A point mutation in the open 
reading frame of the TMV 30-kDa protein gene re- 
sults in temperature-sensitive assembly and local 
lesion spreading of the mutant Ni 2519 [92,93]. In 
neither case are mutations elsewhere in the genome 
excluded. The maximum rate of synthesis of the 
30-kDa protein in infected plants is reached earlier 
than that of other virus-coded proteins [20,40], 
suggesting that the former protein could also 
operate prior to replication of the viral RNA; one 
could speculate that early in infection the function 
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of the 30-kDa protein is to disaggregate the poly- 
somes containing the genomic RNA so as to allow 
the synthesis of - strand RNA of the length of the 
genomic RNA [94]. Alternatively, the 30-kDa pro- 
tein might be involved in the internal initiation of 
transcription of subgenomic mRNA. 
In comoviruses, the independent replication of 
RNA 1 is restricted to the initially infected cells 
[95]; either a protein encoded by RNA 2, or synthe- 
sis of the coat protein and packaging of the viral 
RNA might be required for cell-to-cell movement 
of the virus. 
The short and long distance movements of the 
virus, and the changes in host phenotype upon in- 
fection have recently been reviewed [7]. 
Interestingly, in TRV, RNA 1 alone can replicate 
and migrate from cell to cell, and the symptoms of 
infection are even more severe than those observed 
upon infection with RNAs 1 and 2 together [96]. 
5.4. The helper component 
Aphid transmission of potyviruses is dependent 
on the presence of a virus-coded helper component 
(HC) present in potyvirus-infected cells. Anti-HC 
antibodies not only precipitate the in vitro-syn- 
thesized HC protein (-56 kDa) but also a protein 
of -82 kDa. This implies that proteolytic or other 
post-translation modifications are required to pro- 
duce active HC [97]. 
6. DISCUSSION 
6.1. Discrimination between viral and cellular RNAs 
To discriminate between viral and cellular 
mRNAs during replication, translation and en- 
capsidation of viral particles, specific signals must 
exist on the viral RNAs. 
The last -150 nucleotides at the 3’-end of the 
RNAs of multipartite genome viruses are highly 
conserved. In ilarviruses the coat protein binding 
site is located near the 3’-end of the genome and 
binding of the protein to the RNA is thought to 
trigger viral RNA replication. It seems likely that 
this region of the viral RNAs constitutes the recog- 
nition signal for the synthesis of - RNA strands 
and/or for encapsidation. 
Knowledge of the structure at the 5’-end of viral 
RNAs will provide insight on the features required 
for the synthesis of + strand RNAs and those 
required for efficient translation. Finally, contrary 
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to cellular mRNAs which are capped and poly- 
adenylated, only very few viral RNAs possess both 
these structures. 
quired during infection. It is interesting to note 
that homologous sequences are encountered in the 
non-structural proteins of the viruses using this 
strategy and in picornaviruses 1701. 
6.2. Evaluation of the different strategies used by 
plant RNA viruses of + polarity 6.2.3. Polycistronic: internal initiation 
6.2.1. Functionally monocistronic: use of sub- 
genomic RNAs 
Between 3 and 10 proteins are encoded by viruses 
of this category; the genomic RNAs are often poly- 
genie but are functionally monocistronic, only the 
5’-terminal cistron being expressed. In these 
viruses (see table 1) subgenomic RNAs are synthe- 
sized during infection for the expression of internal 
genes, and these may be more or less efficient in 
translation than the genomic counterparts. Gener- 
ally, the coat protein cistron is 3’-terminal and the 
coat protein is synthesized on a subgenomic RNA. 
Apart from IZ RNA (in the case of TMV) and the 
coat protein mRNA, the function of most other 
subgenomic RNAs is unknown and it is still un- 
clear whether these RNAs are translated in vivo. 
The exact mechanism of the genesis of the sub- 
genomic RNAs is not yet well defined. This strategy 
is highly economica for the virus since it permits 
the synthesis of different virus-coded proteins in 
different amounts. A striking analogy exists 
[60,61] between the amino acid sequences contained 
in certain non-structural proteins of viruses using 
this strategy (AMV, BMV and TMV) and of two 
alphaviruses (Sindbis virus and Middelburg virus). 
CarMV has been reported to be polycistronic 
and to resort to internal mitiation. Since several 
prokaryotic polycistronic mRNAs appear to be 
correctly translated in eukaryotic systems, it is not 
surprising that this strategy could also be used by 
plant viral RNAs. 
6.2.4. One gene - multiple proteins 
Several stretegies are used during translation of 
plant viral RNAs at the leve1 of initiation, elonga- 
tion and termination, leading to the synthesis of 
proteins that have peptides in common. The ratio 
of these proteins varies depending on the strategy 
used. In the case of TYMV RNA, these proteins 
also behave differently during post-translational 
cleavage [76]. Such proteins may fulfil1 different 
functions during virus propagation. 
6.2.5. Multipartite genome 
6.2.2. Functionally monocistronic: post-transla- 
The genome parts of multicomponent viruses 
are separately encapsidated. The ratio of the dif- 
ferent genomic RNAs varies between 1 and 5. For 
infection of a cell, more than one particle is thus 
required, and this reduces the efficiency of mech- 
anical transmission. However, in nature these viru- 
ses are often transmitted by seed or by invertebrate 
vectors allowing large numbers of virus particles to 
enter per cell. 
tional cleavage of polyproteins 
The genomic RNAs of potyviruses are probably 
monocistronic, although evidence for the presence 
and possible functions significance of subgenomic 
RNAs has also been provided [98]. 
The genomic RNAs of como- and nepoviruses are 
monocistronic. The coat protein(s) is (are) encoded 
by one genomic RNA and the replicase by the 
other. Upon transIation of these RNAs, polypro- 
teins are synthesized that are post-translation~ly 
cleaved to liberate mature, functional proteins. 
Unless differential stability exists between the dif- 
ferent mature proteins, one must assume that this 
strategy leads to the appearance in equimolar 
amounts of all the proteins present on the polypro- 
tein, a situation that may not necessarily be re- 
Since RNA-dependent RNA polymerases lack 
error-correcting mechanisms, the estimated error 
frequency for these enzymes lies between 10m3 and 
10m4. Clearly, for a fixed error level, the longer the 
RNA, the greater the possible loss of information. 
This problem may be resolved by the presence of 
multipartite genomes [99]. Since during encapsida- 
tion different genomic RNAs are withdrawn ran- 
domly from the intraceilular pool of RNAs, a 
number of combinations exists and this strategy 
may ensure that the optimally adopted combina- 
tion of composite viruses arises at each round of 
replication. 
With multipartite genome viruses, new pseudo- 
recombinants can be obtained in vitro and in vivo. 
This increase in variability could represent an im- 
171 
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portant evolutionary advantage, especially since 
recombination at the RNA level takes place only at 
low frequency [ 1001. The multipartite genome 
strategy is also well adapted to the translational 
machinery of the host cell which preferentially ini- 
tiates close to the 5’-terminus of mRNAs. Such a 
genome offers the possibility of regulating separ- 
ately, in amount and time, the expression of each 
gene. 
6.3. Regulation of synthesis of viral proteins and 
RNAs 
One obvious function required by the virus 
during infection is replication of its genome. The 
amount of the different genomic/subgenomic 
RNAs, as well as of their translation products, is 
regulated during infection. The relative efficiencies 
of the replication signals for each genomic/sub- 
genomic RNA may determine the amount of the 
different RNAs produced; likewise the S-terminal 
structure and the efficiency of the leader sequence 
for translation may regulate the level of synthesis 
of the different proteins. Various strategies may 
be used during translation producing different 
amounts of normal, readthrough and/or pre- 
mature termination products. 
The time after infection at which different viral 
RNAs are synthesized may depend on the need for 
a specific protein involved in replication, on the 
accessibility of the RNA species for replication, or 
in the case of subgenomic RNA species also on the 
strategy used for their replication. As a result, syn- 
thesis of the viral proteins may be triggered at dif- 
ferent times during infection, depending on the 
availability of the corresponding RNAs and on the 
relative efficiencies of these RNAs in translation. 
The study of plant virus RNAs has already con- 
tributed greatly to our understanding of the dif- 
ferent steps involved in translation as well as of the 
RNA features required for efficient translation. 
An RNA-dependent RNA polymerase is in- 
volved in viral RNA replication and is clearly dif- 
ferent [101,102] from the one detected in healthy 
plants. This latter activity is increased upon rub- 
bing of the leaves in the absence of any virus, and 
also increases in leaves other than those thus 
treated [103]. One can therefore wonder whether 
plants also make use of an RNA-dependent RNA- 
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synthesizing machinery. A few viral RNAs are also 
able to migrate from one cell to another [96]. It 
will be interesting to determine whether host 
mRNAs are also able to migrate from cell to cell. 
The detailed knowledge of the mechanism of 
viral genomic and subgenomic RNA replication, 
translation and encapsidation as well as of the 
functions of the different virus- and host-coded 
proteins involved might allow insertion and expres- 
sion of any desired gene into plant virus genomes 
[104]. A better understanding of virus multiplica- 
tion and propagation should permit detection, 
control and/or prevention of plant diseases, and 
also development of new chromosomal vectors for 
plant genetic engineering. 
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NOTE ADDED IN PROOF 
The complete nucleotide sequence of the CMV 
genomic RNA 2 has been reported [1051. 
REFERENCES 
[I] Plant Infectious Agents: Viruses, Viroids, Viru- 
soids and Satellites (1983) (Robertson, H.D. et al. 
eds) Cold Spring Harbor Laboratory. 
[2] Matthews, R.E.F. (1981) Plant Virology, Aca- 
demic Press, New York. 
[3] Hirth, L. (1982) in: Encyclopedia of Plant Physi- 
ology New Series, Nucleic Acids and Proteins in 
Plants II (Boulter, D. and Parthier, B. eds) 
vol. 14B, pp. 302-336, Springer, Berlin. 
[4] Van Vloten-Doting, L. and Neeleman, L. (1982) 
in: Encyclopedia of Plant Physiology New Series, 
Nucleic Acids and Proteins in Plants II (Boulter, 
D. and Parthier, B. eds) vol. 14B, pp. 337-367, 
Springer, Berlin. 
IS] Davies, J.W. and Hull, R. (1982) 3. Gen. Virol. 
61, I-14. 
Volume 177, number 2 FEBS LETTERS November 1984 
[6] Hall, T.C., Miller, W.A. and Bujarski, J.J. (1982) 
in: Adv. Plant Pathology (Ingram, D.S. and 
Williams, P.H. eds) vol. 1, pp. 179-211, Aca- 
demic Press, New York. 
[7] Van Vloten-Doting, L., Bol, J.F., Nassuth, A., 
Roosien, J. and Sarachu, A.N. (1983) NATO/ASl, 
vol. 63, 437-450. 
[8] Goelet, P., Lomonosoff, G.P., Butler, P.J.G., 
Akem, M.E., Gait, M.J. and Karn, J. (1982) 
Proc. Natl. Acad. Sci. USA 79, 5818-5822. 
[9] Cornelissen, B.J.C., Brederode, F.T., Moorman, 
R.J.M. and Bol, J.F. (1983) Nucleic Acids Res. 
11, 1253-1265. 
[lo] Barker, R.F., Jarvis, N.P., Thompson, D.V., 
Loesch-Fries, L.S. and Hall, T.C. (1983) Nucleic 
Acids Res. 11, 2881-2891. 
[11] Cornelissen, B.J.C., Brederode, F.T., Veeneman, 
G.H., Van Boom, J.H. and Bol, J.F. (1983) 
Nucleic Acids Res. 11, 3019-3025. 
[12] Lomonossoff, G.P. and Shanks, M. (1983) EMBO 
J. 2, 2253-2258. 
[ 131 Van Wezenbeek, P., Verver, J., Harmsen, J., 
Vos, P. and Van Kammen, A. (1983) EMBO J. 2, 
941-946. 
[14] Ahlquist, P., Lukow, V. and Kaesberg, P. (1981) 
J. Mol. Biol. 153, 23-38. 
[15] Ahlquist, P., Dasgupta, R. and Kaesberg, P. 
(1984) J. Mol. Biol. 172, 369-383. 
[16] Cornelissen, B.J.C., Janssen, H., Zuidema, D. 
and Bol, J.F. (1984) Nucleic Acids Res. 12, 
2427-2437. 
[17] Gould, A. and Symons, R.H. (1982) Eur. J. Bio- 
them. 126, 217-226. 
[18] Guilley, H. and Briand, J.P. (1978) Cell 15, 
113-122. 
[l9] Wodnar-Filipowicz, A., Szczesna, E., Zan- 
Kowalczewska, M., Muthukrishnan, S., Szybiak, 
U., Legocki, A.B. and Filipowicz, W. (1978) Eur. 
J. Biochem. 92, 69-80. 
[20] Joshi, S., Pleij, C.W.A., Haenni, A.L., Chapeville, 
F. and Bosch, L. (1983) Virology 127, 100-111. 
[21] Goldbach, R., Franssen, H., Rezelman, G., Van 
Kammen, A., Verver, J. and Van Wezenbeek, P. 
(1983) in: Plant Infectious Agents: Viruses, 
Viroids, Virusoids and Satellites (Robertson, 
H.D. et al. eds) pp. 100-105, Cold Spring Harbor 
Laboratory. 
[22] Haenni, A.L., Joshi, S. and Chapeville, F. (1982) 
Prog. Nucleic Acid Res. Mol. Biol. 27, 85-104. 
[23] Joshi, S., Joshi, R.L., Haenni, A.L. and Chapeville, 
F. (1983) Trends Biochem. Sci. 8, 402-404. 
[24] Joshi, R.L., Joshi, S., Chapeville, F. and Haenni, 
A.L. (1983) EMBO J. 2, 1123-1127. 
[25] Rietveld, K., Pleij, C.W.A. and Bosch, L. (1983) 
EMBO J. 2, 1079-1085. 
[26] Kozlov, Yu.V., Rupasov, V.V., Adyshev, D.M. 
and Belgelarskaya, S.N. (1984) Nucleic Acids Res. 
4001-4009. 
[27] Kumarasamy, R. and Symons, R.H. (1979) 
Virology 96, 622-632. 
[28] Bujarski, J.J., Hardi, S.F., Miller, W.A. and 
Hall, T.C. (1982) Virology 119, 465-473. 
[29] Mouches, C., Candresse, T. and Bove, J.M. 
(1984) Virology 134, 78-90. 
[30] Kiberstis, P.A. and Hall, T.C. (1983) J. Gen. 
Virol. 64, 2073-2077. 
[31] Huez, G., Cleuter, Y., Bruck, C., Van Vloten- 
Doting, L., Goldbach, R. and Verduin, B. (1983) 
Eur. J. Biochem. 130, 205-209. 
[32] Agranovsky, A.A., Dolja, V.V. and Atabekov, 
J.G. (1982) Virology 119, 51-58. 
[33] Smit, C.H., Roosien, J., Van Vloten-Doting, L. 
and Jaspars, E.M.J. (1981) Virology 112, 169- 
173. 
[34] Hunter, T.R., Hunt, T., Knowland, J. and 
Zimmern, D. (1976) Nature 260, 759-764. 
[35] Beachy, R.N. and Zaitlin, M. (1977) Virology 81, 
160-169. 
[36] Pelham, H.R.B. (1978) Nature, 469-471. 
[37] Scalla, R., Romaine, P., Asselin, A., Rigaud, J. 
and Zaitlin, M. (1978) Virology 91, 182-193. 
[38] Pelham, H.R.B. (1979) Virology 97, 256-265. 
[39] Hirth, L. and Richards, K. (1981) Adv. Virus Res. 
26, 145-199. 
[40] Ooshika, I., Watanabe, Y., Meshi, T., Okada, 
Y., Igano, K., Inouye, K. and Yoshida, N. (1984) 
Virology 132, 71-78. 
[41] Watanabe, Y., Emori, Y., Ooshika, I., Meshi, T., 
Ohno, T. and Okada, Y. (1984) Virology 133, 
18-24. 
[42] Mayo, M.A. (1982) Intervirology 17, 240-265. 
[43] Bisaro, D.M. and Siegel, A. (1982) Virology 118, 
411-418. 
[44] Franssen, H., Goldbach, R., Broekhuijsen, M., 
Moerman, M. and Van Kammen, A. (1982) J. 
Virol. 41, 8-17. 
1451 Goldbach, R. and Rezelman, G. (1983) J. Virol. 
46, 614-619. 
[46] Franssen, H., Moerman, M., Rezelman, G. and 
Goldbach, R. (1984) J. Virol. 50, 183-190. 
[47] Sakai, F., Dawson, J.R.O. and Watts, J.W. 
(1979) J. Gen. Virol. 42, 323-328. 
[48] Okuno, T. and Furasawa, I. (1979) Virology 99, 
218-225. 
[49] Kibertis, P.A., Loesch-Fries, L.S. and Hall, T.C. 
(1981) Virology 112, 804-808. 
[50] Rutgers, A.S. (1977) Ph.D. Thesis, State Univer- 
sity of Leiden, The Netherlands. 
[51] Van Tol, R.G.L. and Van Vloten-Doting, L. 
(1979) Eur. J. Biochem. 93, 461-468. 
[52] Van Tol, R.G.L., Van Gemeren, R. and Van 
Vloten-Doting, L. (1980) FEBS Lett. 118, 67-71. 
[53] Nassuth, A., Alblas, F. and Bol, J.F. (1981) J. 
Gen. Virol. 53, 207-214. 
173 
Volume 177, number 2 FEBS LETTERS November 1984 
WI 
[551 
1561 
[571 
WI 
1591 
WI 
HI 
WI 
1631 
WI 
I651 
WI 
f671 
WI 
W91 
[701 
[711 
[721 
1731 
[741 
1751 
[76l 
[771 
174 
Samac, D.A., Nelson, S.E. and Loesch-Fries, 
L.S. (1983) Virology 131, 455-462. 
Joshi, S,, Neeleman, L., Pleij, C.W.A., Haenni, 
A.L., Chapeville, F., Bosch, L. and Van Vloten- 
Doting, L. (1984) Virology 138, in press. 
Sakai, F., Watts, J.W., Dawson, J.R.D. and 
Bancroft, J.B. (1977) J. Gen. Virol. 34, 285-293. 
Davies, J.W. and Verduin, B. J.M. (1979) J. Gen. 
Viral. 44, 545-549. 
Gustafson, G.D., Larkins, B.A. and Jackson, 
A.O. (1981) Virology 111, 579-587. 
Dolja, V.V., Lunia, N.A., Leiser, R.M. Stanarius, 
T., Belzhel~skaya, S.N., Kozlov, Yu.V. and 
Atabekov, J.G. (1983) Virology 127, I-14. 
Cornelissen, B.J.C. and Bol, J.F. (1984) Plant. 
Mol. Biol., in press. 
Haseloff, J., Goelet, P., Zimmern, D., Ahlquist, 
P., Dasgupta, R. and Kaesberg, P, (1984) Proc. 
Nati. Acad. Sci. USA 81, 4358-4362. 
Safomon, R., Bar-Joseph, M., Soreq, H., Gozes, 
I. and Littauer, U.Z. (1978) Virology 90, 288- 
298. 
Zuidema, D., Bierhuizen, M.F.A., Cornelissen, 
B.J.C., Bol, J.F. and Jaspars, E.M.J. (1983) 
Virobgy 125, 361-369. 
March, M.D. and Benicourt, C. (1980) Eur. J. 
Biochem. 105, 445-451. 
Bienz, M. and Kubli, E. (1981) Nature 294, 
188-190. 
Beier, H., Barciszewska, M., Krupp, G., Mitnacht, 
R. and Gross, H.J. (1984) EMBO J. 3, 351-356. 
Beier, H., Barciszewska, M. and Sickinger, H.D. 
(1984) EMBO J. 3, 1091-1096. 
Siegel, A., Hari, V. and Kolacz, K. (1978) 
Virology 85, 495-503. 
Franssen, H., Goldbach, R. and Van Kammen, 
A. (1984) Virus Res. 1, 39-50. 
Franssen, H., Leunissen, J., Goldbach, R., 
Lomonossoff, ct. and Zimmern, D. (1984) EMBO 
J. 3, 855-861. 
Fritsch, C., Mayo, M.A. and Murant, A.F. (1980) 
J. Gen. Virol. 46, 381-389. 
Dougherty, W.G. and Hiebert, E. (1980) Virology 
104, 183-194. 
Hellmann, G.M., Thornbury, D.W., Hiebert, E., 
Shaw, J.G., Pirone, T.P. and Rhoads, R.E. 
(1983) Virology 124, 434-444. 
Vance, V.B. and Beachy, R.N. (1984) Virology 
132, 271-281. 
Putnak, J.R. and Phillips, B.A. (1981) Microbial. 
Rev. 45, 287-315. 
March, M.D. and Benicourt, C. (1980) J. Virol. 
34, 85-94. 
March, M.D., Zagorski, W. and Haenni, A.L. 
(1982) Eur. J. Biochem. 127, 259-265. 
1781 
[791 
WI 
WI 
PI 
1831 
1841 
P351 
WI 
I871 
WI 
1891 
PI 
[911 
t921 
[931 
[941 
[951 
1961 
[971 
[981 
[991 
ww 
[loll 
11021 
I1031 
HO41 
11051 
Zagorski, W. (1978) Eur. J. Biochem. 86, 465- 
472. 
Benicourt, C. and Haenni, A.L. (1978) Biochem. 
Biophys. Res. Commun. 84, 831-839. 
Chroboczek, J., Puchkova, L. and Zagorski, W, 
(1980) J. Virol. 34, 330-335. 
Collmer, C-W., Vogt, V.M. and Zaitlin, M. 
(1983) Virology 126, 429-448. 
Collmer, C.W. and Zaitlin, M. (1983) Virology 
126, 449-458. 
Zuidema, D., Bierhuizen, M.F.A. and Jaspars, 
E.M.J. (1983) Virology 129, 255-260. 
Dawson, W.O. and White, J.L. (1978) Virology 
90, 209-213. 
Dawson, W.O. and White, J.L. (1979) Virology 
93, 104-l 10. 
Dorssers, L., Van der Krol, S., Van der Meer, J., 
Van Kammen, A. and Zabel, P. (1984) Proc. 
Natl. Acad. Sci. USA 81, 1951-1955. 
Nassuth, A. and Bol, J.F. (1983) Virology 124, 
75-85. 
Mayo, M.A. and Barker, H. (1983) J. Gen. Virol. 
64, 1775-1780. 
Rottier, P.J.M., Rezelman, G. and Van Kammen, 
A. (1979) Virology 92, 299-309. 
Leonard, D.A. and Zaitlin, M. (1982) Virology 
117, 416-424. 
Ohno, T., Takamatsu, N., Meshi, T., Okada, Y., 
Nishiguchi, M. and Kiho, Y. (1983) Virology 131, 
255-258. 
Zimmern, D. and Hunter, T. (1983) EMBO J. 2, 
1893-1900. 
Zimmern, D. (1983) EMBO J. 2, 1901-1907. 
Joshi, S. (1983) D.Sc. Thesis, University of Paris 
VII, France. 
Rezelman, G., Franssen, H.J., Goldbach, R.W., 
Ie, T.S. and Van Kammen, A. (1982) J. Gen. 
Virol. 60, 335-342. 
Harrison, B.D. and Robinson, D.J. (1978) Adv. 
Virus Res. 23, 25-77. 
Hiebert, E., Thronbury, D.W. and Pirone, T.P. 
(1984) Virology 13.5, l-9. 
Otal, T. and Hari, V. (1983) Virology 125, 
118-126. 
Reanney, D.C. (1982) Annu. Rev. Microbial. 36, 
47-73. 
King, A.M.Q., McCahon, D., Slade, W.R. and 
Newmann, J.W.I. (1982) Cell 29, 921-928. 
Van der Meer, J., Dorssers, L., Van Kammen, A. 
and Zabel, P. (1984) Virology 132, 413-425. 
Miller, W.A. and Hall, T.C. (1984) Virology 132, 
53-60. 
Fraenkel-Conrat, H. (1983) Proc. Natl. Acad. Sci. 
USA 80, 422-424. 
Van Vloten-Doting, L. (1982) Plant Mol. Biol. 
Reporter 1, 55-60. 
Rezaian et al. (1984) Eur. J. Biochem. 143, 
277-284. 
